Since hepatic SHP is recognized as a critical regulator in BA synthesis, we assessed the involvement of gut microbiota in the antiobesity and anti-NASH phenotype of Shp−/− mice. This evidence concerns the gene NR0B2 and metabolic dysfunction-associated steatohepatitis.